SCHEMBL182191

SCHEMBL182191

C1NCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL44386 0.91
SCHEMBL4140732 0.91
SCHEMBL17366418 0.91 HIF1A (0.33)
Methane SCHEMBL16241315 0.84 HIF1A (0.30)
Ammonia Solution, Strong SCHEMBL27794312 0.84
SCHEMBL5706376 0.84
SCHEMBL658240 0.84 HIF1A (0.30)
SCHEMBL149667 0.79
Ethylene SCHEMBL28083938 0.79
SCHEMBL5616852 0.74 HIF1A (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076059-A1 ROCAGLATE DERIVATIVES AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-04-10 WO claimed
CN-118105513-A Conjugates comprising self-degrading groups and methods related thereto 乐高化学生物科学股份有限公司 2024-05-31 CN claimed
US-11897796-B2 Compositions of heterocyclic compounds and uses as sulfidogenesis inhibitors CHAMPIONX USA INC. (US) 2024-02-13 US claimed
US-20240001281-A1 IMPROVED MATERIALS FOR DIRECT AIR CAPTURE AND USES THEREOF CLIMEWORKS AG (CH) 2024-01-04 US claimed
EP-4263026-A1 IMPROVED MATERIALS FOR DIRECT AIR CAPTURE AND USES THEREOF Climeworks AG (CH) 2023-10-25 EP claimed
CN-115776907-A MTORC1 modulators and uses thereof 艾奥维安制药公司 2023-03-10 CN claimed
EP-4126229-A1 MTORC1 MODULATORS AND USES THEREOF Aeovian Pharmaceuticals, Inc. (US) 2023-02-08 EP claimed
EP-4093836-A1 COMPOSITIONS OF HETEROCYCLIC COMPOUNDS AND USES AS SULFIDOGENESIS INHIBITORS ChampionX USA Inc. (US) 2022-11-30 EP claimed
WO-2022128431-A1 IMPROVED MATERIALS FOR DIRECT AIR CAPTURE AND USES THEREOF CLIMEWORKS AG (CH) 2022-06-23 WO claimed
WO-2021195599-A1 MTORC1 MODULATORS AND USES THEREOF AEOVIAN PHARMACEUTICALS, INC. (US) 2021-09-30 WO claimed
WO-2021151083-A1 COMPOSITIONS OF HETEROCYCLIC COMPOUNDS AND USES AS SULFIDOGENESIS INHIBITORS CHAMPIONX USA INC. (US) 2021-07-29 WO claimed
US-20200392259-A1 ORTHOMETALLATED CATALYST COMPONENTS FOR OLEFIN POLYMERIZATION AND COPOLYMERIZATION ARZOUMANIDIS GREGORY G (US) 2020-12-17 US claimed
JP-4676960-B2 2011-04-27 JP claimed
US-7196103-B2 Indole derivatives as factor Xa inhibitors SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-03-27 US claimed
JP-2006528940-A 2006-12-28 JP claimed
EP-1633746-A1 NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS Sanofi-Aventis Deutschland GmbH (DE) 2006-03-15 EP claimed
US-20050033049-A1 Indole derivatives as factor Xa inhibitors AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-02-10 US claimed
WO-2004101554-A1 NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2004-11-25 WO claimed
EP-1479677-A1 New indole derivatives as factor xa inhibitors Aventis Pharma Deutschland GmbH (DE) 2004-11-24 EP claimed
WO-1999011612-A2 SUBSTITUTED CYCLIC COMPOUNDS AND MIXTURES COMPRISING SAME ISIS PHARMACEUTICALS, INC. (US) 1999-03-11 WO claimed